249 related articles for article (PubMed ID: 23542511)
1. Calpains mediate axonal cytoskeleton disintegration during Wallerian degeneration.
Ma M; Ferguson TA; Schoch KM; Li J; Qian Y; Shofer FS; Saatman KE; Neumar RW
Neurobiol Dis; 2013 Aug; 56():34-46. PubMed ID: 23542511
[TBL] [Abstract][Full Text] [Related]
2. Role of calpains in the injury-induced dysfunction and degeneration of the mammalian axon.
Ma M
Neurobiol Dis; 2013 Dec; 60():61-79. PubMed ID: 23969238
[TBL] [Abstract][Full Text] [Related]
3. Very early activation of m-calpain in peripheral nerve during Wallerian degeneration.
Glass JD; Culver DG; Levey AI; Nash NR
J Neurol Sci; 2002 Apr; 196(1-2):9-20. PubMed ID: 11959150
[TBL] [Abstract][Full Text] [Related]
4. ATF3 upregulation in glia during Wallerian degeneration: differential expression in peripheral nerves and CNS white matter.
Hunt D; Hossain-Ibrahim K; Mason MR; Coffin RS; Lieberman AR; Winterbottom J; Anderson PN
BMC Neurosci; 2004 Mar; 5():9. PubMed ID: 15113454
[TBL] [Abstract][Full Text] [Related]
5. Intra-axonal calcium changes after axotomy in wild-type and slow Wallerian degeneration axons.
Adalbert R; Morreale G; Paizs M; Conforti L; Walker SA; Roderick HL; Bootman MD; Siklós L; Coleman MP
Neuroscience; 2012 Dec; 225():44-54. PubMed ID: 22960623
[TBL] [Abstract][Full Text] [Related]
6. Calpastatin overexpression protects axonal transport in an in vivo model of traumatic axonal injury.
Ma M; Shofer FS; Neumar RW
J Neurotrauma; 2012 Nov; 29(16):2555-63. PubMed ID: 22776025
[TBL] [Abstract][Full Text] [Related]
7. The endogenous calpain inhibitor calpastatin attenuates axon degeneration in murine Guillain-Barré syndrome.
McGonigal R; Cunningham ME; Smyth D; Chou M; Barrie JA; Wilkie A; Campbell C; Saatman KE; Lunn M; Willison HJ
J Peripher Nerv Syst; 2023 Mar; 28(1):4-16. PubMed ID: 36335586
[TBL] [Abstract][Full Text] [Related]
8. Wallerian-like axonal degeneration in the optic nerve after excitotoxic retinal insult: an ultrastructural study.
Saggu SK; Chotaliya HP; Blumbergs PC; Casson RJ
BMC Neurosci; 2010 Aug; 11():97. PubMed ID: 20707883
[TBL] [Abstract][Full Text] [Related]
9. Axotomy-induced cytoskeleton changes in unmyelinated mammalian central nervous system axons.
Balaratnasingam C; Morgan WH; Bass L; Kang M; Cringle SJ; Yu DY
Neuroscience; 2011 Mar; 177():269-82. PubMed ID: 21215300
[TBL] [Abstract][Full Text] [Related]
10. Quantification of the mononuclear phagocyte response to Wallerian degeneration of the optic nerve.
Lawson LJ; Frost L; Risbridger J; Fearn S; Perry VH
J Neurocytol; 1994 Dec; 23(12):729-44. PubMed ID: 7897440
[TBL] [Abstract][Full Text] [Related]
11. The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves.
Beirowski B; Adalbert R; Wagner D; Grumme DS; Addicks K; Ribchester RR; Coleman MP
BMC Neurosci; 2005 Feb; 6():6. PubMed ID: 15686598
[TBL] [Abstract][Full Text] [Related]
12. Rescuing axons from degeneration does not affect retinal ganglion cell death.
de Lima S; Mietto BS; Paula C; Muniz T; Martinez AM; Gardino PF
Braz J Med Biol Res; 2016; 49(4):e5106. PubMed ID: 27007653
[TBL] [Abstract][Full Text] [Related]
13. Loss of the compound action potential: an electrophysiological, biochemical and morphological study of early events in axonal degeneration in the C57BL/Ola mouse.
Tsao JW; Brown MC; Carden MJ; McLean WG; Perry VH
Eur J Neurosci; 1994 Apr; 6(4):516-24. PubMed ID: 8025707
[TBL] [Abstract][Full Text] [Related]
14. The fate of axonal debris in Wallerian degeneration of rat optic and sciatic nerves. Electron microscopy and immunofluorescence studies with neurofilament antisera.
Bignami A; Dahl D; Nguyen BT; Crosby CJ
J Neuropathol Exp Neurol; 1981 Sep; 40(5):537-50. PubMed ID: 7024479
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of axonal spheroid formation in central nervous system Wallerian degeneration.
Beirowski B; Nógrádi A; Babetto E; Garcia-Alias G; Coleman MP
J Neuropathol Exp Neurol; 2010 May; 69(5):455-72. PubMed ID: 20418780
[TBL] [Abstract][Full Text] [Related]
16. Loss of translation elongation factor (eEF1A2) expression in vivo differentiates between Wallerian degeneration and dying-back neuronal pathology.
Murray LM; Thomson D; Conklin A; Wishart TM; Gillingwater TH
J Anat; 2008 Dec; 213(6):633-45. PubMed ID: 19094180
[TBL] [Abstract][Full Text] [Related]
17. Axonal and neuromuscular synaptic phenotypes in Wld(S), SOD1(G93A) and ostes mutant mice identified by fiber-optic confocal microendoscopy.
Wong F; Fan L; Wells S; Hartley R; Mackenzie FE; Oyebode O; Brown R; Thomson D; Coleman MP; Blanco G; Ribchester RR
Mol Cell Neurosci; 2009 Dec; 42(4):296-307. PubMed ID: 19683573
[TBL] [Abstract][Full Text] [Related]
18. Watery and dark axons in Wallerian degeneration of the opossum's optic nerve: different patterns of cytoskeletal breakdown?
Narciso MS; Hokoç JN; Martinez AM
An Acad Bras Cienc; 2001 Jun; 73(2):231-43. PubMed ID: 11404785
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of alpha-synuclein in the nervous system enhances axonal degeneration after peripheral nerve lesion in a transgenic mouse strain.
Siebert H; Kahle PJ; Kramer ML; Isik T; Schlüter OM; Schulz-Schaeffer WJ; Brück W
J Neurochem; 2010 Aug; 114(4):1007-18. PubMed ID: 20524960
[TBL] [Abstract][Full Text] [Related]
20. Effect of Lycium barbarum (Wolfberry) on alleviating axonal degeneration after partial optic nerve transection.
Li HY; Ruan YW; Kau PW; Chiu K; Chang RC; Chan HH; So KF
Cell Transplant; 2015; 24(3):403-17. PubMed ID: 25622224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
